← The Wire
PLRXNasdaq
PLIANT THERAPEUTICS, INC.
Pharmaceutical Preparations · DE · CIK 1746473
PLIANT THERAPEUTICS, INC. researches, promotes, sells, and markets healthcare items and services subject to extensive laws
red 8-K · 90d
$70M
Market cap
$1.15
Last close
+0.9%
1D
-0.9%
5D
288K
Volume
Price · last 39 sessions-3.4%
May 4L $1.13 · H $1.26Jun 29
126
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 11, 202610-Q10-QMay 11, 20268-KResults of OperationsMay 11, 2026DEFA14ADEFA14AApr 22, 2026DEF 14ADEF 14AApr 22, 20268-KExecutive ChangeApr 17, 20268-KCompany UpdateMar 30, 20268-KResults of OperationsMar 11, 202610-K10-KMar 11, 20268-KMaterial Agreement · Security-Holder RightsMar 3, 20268-KExecutive ChangeDec 16, 20258-KExecutive ChangeDec 8, 202510-Q10-QNov 6, 20258-KResults of OperationsNov 6, 20258-KExecutive ChangeOct 24, 20258-KAgreement TerminatedOct 20, 202510-Q10-QAug 7, 20258-KCompany UpdateAug 7, 20258-KBylaw Amendment · Shareholder VoteJun 9, 202510-Q10-QMay 8, 20258-KResults of OperationsMay 8, 20258-KExecutive Change · Exit / Disposal CostsMay 1, 2025DEFA14ADEFA14AApr 23, 2025DEF 14ADEF 14AApr 23, 20258-KMaterial Agreement · Security-Holder RightsMar 13, 202510-K10-KMar 3, 20258-KResults of OperationsMar 3, 20258-KCompany UpdateFeb 13, 20258-KCompany UpdateFeb 10, 2025SC 13GSC 13GNov 14, 202410-Q10-QNov 7, 20248-KResults of OperationsNov 7, 2024SC 13GSC 13GOct 4, 20248-KBylaw AmendmentSep 27, 202410-Q10-QAug 7, 20248-KResults of OperationsAug 7, 20248-KCompany UpdateJul 15, 20248-KExecutive Change · Shareholder VoteJun 14, 20248-KCompany UpdateMay 14, 202410-Q10-QMay 6, 20248-KResults of OperationsMay 6, 2024DEFA14ADEFA14AApr 22, 2024DEF 14ADEF 14AApr 22, 20248-KMaterial Agreement · New Debt / ObligationMar 12, 202410-K10-KFeb 27, 20248-KResults of OperationsFeb 27, 2024SC 13GSC 13GFeb 14, 2024SC 13GACQUISITION OF BENEFICIAL OWNERSHIPFeb 14, 2024SC 13GSC 13GFeb 14, 2024SC 13GSCHEDULE 13GFeb 13, 2024SC 13GSC 13GFeb 8, 20248-KCompany UpdateFeb 5, 2024SC 13GSC 13GJan 25, 202410-Q10-QNov 9, 20238-KResults of OperationsNov 9, 20238-KMaterial Agreement · Agreement TerminatedOct 3, 20238-KCompany UpdateSep 26, 202310-Q10-QAug 9, 20238-KResults of OperationsAug 9, 20238-KShareholder VoteJun 8, 202310-Q10-QMay 9, 20238-KResults of OperationsMay 9, 20238-KCompany UpdateMay 1, 2023DEFA14ADEFA14AApr 27, 2023DEF 14ADEF 14AApr 26, 2023SC 13GSC 13GMar 20, 202310-K10-KMar 9, 20238-KResults of OperationsMar 9, 20238-KExecutive ChangeMar 8, 20238-KAgreement TerminatedFeb 23, 20238-KResults of Operations · Company UpdateJan 25, 2023424B5424B5Jan 25, 2023424B5424B5Jan 23, 20238-KCompany UpdateJan 23, 20238-KCompany UpdateJan 23, 20238-KReg FD DisclosureJan 9, 20238-KExecutive ChangeNov 18, 202210-Q10-QNov 8, 20228-KResults of OperationsNov 8, 20228-KExecutive Change · Bylaw AmendmentSep 16, 2022
Insider Activity
In the 90 days to Jan 20, 2026: 4 sold $164K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 20, 2026 | Coulie BernardPresident and CEO | Sell | 89,375 | $1.28 | $114K |
| Jan 20, 2026 | Cummings Keith LamontChief Financial Officer | Sell | 24,002 | $1.28 | $31K |
| Jan 20, 2026 | Cheung LilyChief Human Resource Officer | Sell | 7,534 | $1.28 | $10K |
| Jan 20, 2026 | Kuo MinnieChief Operating Officer | Sell | 6,917 | $1.28 | $9K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance